FibroBiologics' shareholders approve capital stock decrease, elect directors

FibroBiologics, Inc.

Shareholders elected Richard Cilento and Robert Hoffman as Class I directors for terms expiring 2027; both received over 47M votes for.
Capital Decrease Amendment to reduce authorized capital stock approved with ~48.2M for, 11K against; filed Aug 27.
Clarifying Amendment to eliminate obsolete provisions approved; Amended and Restated Certificate of Incorporation effective Aug 27.
WithumSmith+Brown ratified as independent auditor for FY2024 with 54.95M for votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.